|
|
 |
|
Total Number of Holdings (excluding cash): 51
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
150 |
$45,027.00 |
2.45% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
10,500 |
$42,918.14 |
2.34% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,240 |
$41,300.02 |
2.25% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
495 |
$41,248.35 |
2.25% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,268 |
$40,156.06 |
2.19% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,285 |
$40,077.74 |
2.18% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,940 |
$39,397.51 |
2.15% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
361 |
$39,020.05 |
2.13% |
| Teleflex Incorporated |
TFX |
879369106 |
326 |
$39,084.14 |
2.13% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
86 |
$38,902.10 |
2.12% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
427 |
$38,686.20 |
2.11% |
| Masimo Corporation |
MASI |
574795100 |
216 |
$38,493.36 |
2.10% |
| Align Technology, Inc. |
ALGN |
016255101 |
223 |
$38,329.24 |
2.09% |
| Penumbra, Inc. |
PEN |
70975L107 |
117 |
$37,984.05 |
2.07% |
| Agilent Technologies, Inc. |
A |
00846U101 |
335 |
$37,580.30 |
2.05% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
337 |
$37,585.61 |
2.05% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,434 |
$37,577.96 |
2.05% |
| Baxter International Inc. |
BAX |
071813109 |
2,250 |
$37,395.00 |
2.04% |
| Revvity, Inc. |
RVTY |
714046109 |
430 |
$37,199.30 |
2.03% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,711 |
$36,988.73 |
2.02% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
167 |
$37,030.60 |
2.02% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
574 |
$36,627.69 |
2.00% |
| Steris Plc |
STE |
G8473T100 |
173 |
$36,719.25 |
2.00% |
| Alcon Inc. |
ALC.SW |
H01301128 |
494 |
$36,504.82 |
1.99% |
| Becton, Dickinson and Company |
BDX |
075887109 |
250 |
$36,577.50 |
1.99% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
29 |
$36,555.66 |
1.99% |
| Waters Corporation |
WAT |
941848103 |
121 |
$36,527.48 |
1.99% |
| LivaNova Plc |
LIVN |
G5509L101 |
615 |
$36,328.05 |
1.98% |
| DexCom, Inc. |
DXCM |
252131107 |
603 |
$36,204.12 |
1.97% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,860 |
$36,207.37 |
1.97% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
78 |
$36,082.80 |
1.97% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,299 |
$35,695.27 |
1.95% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
138 |
$35,584.68 |
1.94% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,355 |
$35,685.42 |
1.94% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
871 |
$35,518.39 |
1.94% |
| Boston Scientific Corporation |
BSX |
101137107 |
624 |
$35,474.40 |
1.93% |
| Danaher Corporation |
DHR |
235851102 |
203 |
$35,330.12 |
1.93% |
| ResMed Inc. |
RMD |
761152107 |
169 |
$35,393.67 |
1.93% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
565 |
$35,035.65 |
1.91% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
193 |
$35,097.06 |
1.91% |
| Medtronic Plc |
MDT |
G5960L103 |
442 |
$34,608.60 |
1.89% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$34,364.58 |
1.87% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
414 |
$34,225.38 |
1.86% |
| Abbott Laboratories |
ABT |
002824100 |
385 |
$33,702.90 |
1.84% |
| Insulet Corporation |
PODD |
45784P101 |
196 |
$33,592.44 |
1.83% |
| The Cooper Companies, Inc. |
COO |
216648501 |
542 |
$33,343.84 |
1.82% |
| Stryker Corporation |
SYK |
863667101 |
114 |
$33,160.32 |
1.81% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
527 |
$32,147.00 |
1.75% |
| BioMerieux |
BIM.FP |
F1149Y232 |
365 |
$30,199.70 |
1.65% |
| Cochlear Limited |
COH.AU |
Q25953102 |
317 |
$22,794.38 |
1.24% |
| US Dollar |
$USD |
|
7,587 |
$7,586.50 |
0.41% |
| Japanese Yen |
$JPY |
|
44,982 |
$286.09 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|